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Abstract 
A system for exhaled breath non-invasive collection, storage, delivery and analysis represents a breakthrough for diagnostic 
application in clinical routine. It gives the opportunity to perform standard measurements in a multicenter context opening the 
way to a chemical phenotyping of respiratory diseases usually defined in terms of physical parameters. The complete measure 
chain is composed of: an innovative and EU-patented device for exhaled breath collection onto an adsorbing cartridge; an 
apparatus for the thermal desorption of the cartridge and a novel gas sensor array based on quartz micro balances functionalized 
with sensing materials of biological source. The populations of the pilot study are: 5 control subjects and 20 Chronic Obstructive 
Pulmonary Diseased (COPD) patients at four different stages, correctly discriminated in 88% of the cases; a larger population of 
71 COPD patients and 93 individual suspected of Obstructive Sleep Apnea Syndrome (OSAS), discriminated with 79% of 
correct classification. 
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1. Introduction 
The determination of the chemical signature of a respiratory disease in the exhaled breath permits the 
following points to be achieved: ambulatory or remote follow-up of respiratory patients; targeting of responsiveness 
to different topical bronchodilators; chemical phenotyping of respiratory diseases as an alternaitve to that based on 
clinical and respiratory function parameters. Moreover, the exhaled breath collection method here proposed is non 
invasive at all and, as consequence, suitable for diagnostic purposes in people unable to perform spirometry. 
Furthermore, this work considers most of the problems currently affecting breath-fingeprinting: lack of standard 
procedures, sample transportability, shared interpretation, adequate consideration of the confounding factors. 
Comorbidities are carefully diagnosed in order to weigh their impact on breath fingerprint, also by correlating 
several clinical parameters and the breath fingerprints. The study here presented has been conducted on populations 
of COPD and OSAS patients, whose exhaled breath fingerptinting potentialities have been already reported in 
literature [1, 2]. 
 
2. Materials and Methods 
The exhaled breath collection is performed by a subject normally breathing into a device [3] (see figure 1), 
which is able to adsorb the volatiles on a cartridge,and easily transported and stored. 
 
 
Fig. 1. Pneumopipe overview [2] 
 
Moreover, thermal desorption taking advantages on preconcentration improves sensor resolution. The transducers 
used for the gas sensor array are quartz crystals with a resonance frequency of about 20 MHz in the thickness shear 
mode. The sensing material covering each crystal is a combination of anthocyanins extracted by three different plant 
tissues: red rose, red cabbage, blue hortensia [4]. 
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Fig. 2. Schematic overview of the whole process 
The electronic board, controlling the whole system, is based on a STM 32 F303VC, fabricated by ST 
Microelectronics. The final result is a fingeprint of 28 sensors responses (see figure 2). The 25 COPD patients are 
divided in groups of 5, each at a different stage with reference to the Gold Standard (0: normal control; GOLD1, 
GOLD2, GOLD3, GOLD4).A larger population of 71 COPD patients and 93 individual suspected of Obstructive 
Sleep Apnea Syndrome (OSAS) has also been involved in this study. In fact, comorbidities represent a crucial point 
for breath-printing testing in terms of efficacy, and OSAS is a common confounding factor for COPD. 
3. Results 
Grouping the 1, 2 and 3 stages, a Partial Least Square model built on the collected data gives a 100% correct 
prediction of the control and of the GOLD4 individuals (see Table 1).  
Table 1. COPD stage discrimination 
 Control 
(predicted) 
 COPD stage 1-2-
3 (predicted) 
 COPD stage 4 
(predicted) 
 
Control (actual) 5 0  0  
COPD stage 1-2-3 (actual) 0 12  3  
COPD stage 4 (actual) 0 0  5  
  
Moreover, COPD and OSAS are correctly discriminated in 79% of the cases (see Table 2). It is worth remarking 
that both diseases coexist in the majority of the 25 patients not correctly classified, although actual group 
membership is based on the main disease.  
-  Multivariate data analysis 
-  Comparison with library 
-  Model elaboration 
-  Classification 
-  Reproducibility test 
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   Table 2. COPD, OSAS discrimination 
 OSAS (predicted) COPD (predicted) 
OSAS (actual) 41 9 
COPD (actual) 16 34 
   
 
4. Conclusions 
Disease staging and its discrimination with respect to a similar or often co-existent pathology is a crucial point to 
test diagnostic ability of an innovative medical tool. These results represent an excellent starting point for a breath-
print based investigation on respiratory diseases. Indeed, the clinical diagnosis and monitoring of COPD is currently 
based on physical parameters, mainly on lung function indexes. The breath-print approach instead founds diagnostic 
and discriminative properties based on chemical information, i. e. on the evaluation of the volatile signature of the 
exhaled breath. These considerations open the way to a chemical phenotyping of respiratory diseases, thus 
integrating the usual diagnostic process commonly based on symptoms and respiratoy volumes and flows. 
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